Mirahype 50mg Tablet ER
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Mirabegron (50mg)
Overview Mirahype 50mg Tablet ER
Extended-release Mirahype 50mg tablets alleviate overactive bladder symptoms such as urinary urgency, frequency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your physician's prescribed dosage and duration. Mirahype 50mg ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects immediately to your doctor. Prior to commencing treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.
Uses of Mirahype 50mg Tablet ER
Managing overactive bladder (OAB) symptoms
Major Benefits of Mirahype 50mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mirahype 50mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Mirahype 50mg Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Mirahype 50mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirahype 50mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Mirahype 50mg Tablet ER works:
Extended-release Mirahype 50mg tablets function as a beta-3 adrenergic agonist. Their mechanism involves bladder receptor stimulation, resulting in detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Mirahype 50mg Extended-Release Tablets requires caution. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mirahype 50mg tablets may pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mirahype 50mg tablets are likely unsafe for breastfeeding mothers. Preliminary human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mirahype 50mg Extended-Release Tablets.
KidneyCAUTION
Extended-release Mirahype 50mg tablets require careful administration in individuals with advanced kidney impairment. Dosage modification for Mirahype 50mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Mirahype 50mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Mirahype 50mg Extended-Release Tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Mirahype 50mg Tablet ER :
Should you forget a Mirahype 50mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mirahype 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Anilide-based Compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Action Class | Selective beta-3 adrenergic agonist (for bladder) |



